PlumX Metrics
Embed PlumX Metrics

Chronic Immune Sensory Polyradiculopathy (CISP): A Systematic Review of the Literature

Neurology International, ISSN: 2035-8377, Vol: 16, Issue: 6, Page: 1214-1222
2024
  • 0
    Citations
  • 0
    Usage
  • 0
    Captures
  • 2
    Mentions
  • 0
    Social Media
Metric Options:   Counts1 Year3 Year

Metrics Details

  • Mentions
    2
    • Blog Mentions
      1
      • 1
    • News Mentions
      1
      • 1

Most Recent Blog

Neurology International, Vol. 16, Pages 1214-1222: Chronic Immune Sensory Polyradiculopathy (CISP): A Systematic Review of the Literature

Neurology International, Vol. 16, Pages 1214-1222: Chronic Immune Sensory Polyradiculopathy (CISP): A Systematic Review of the Literature Neurology International doi: 10.3390/neurolint16060092 Authors: Saurabh Singhal Rahul

Most Recent News

Reports from Opelousas Advance Knowledge in Polyradiculopathy [Chronic Immune Sensory Polyradiculopathy (CISP): A Systematic Review of the Literature]

2025 JAN 10 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Daily -- New study results on polyradiculopathy have been published.

Review Description

Chronic immune sensory polyradiculopathy (CISP) is a rare inflammatory immune disorder affecting the nervous system, primarily targeting the proximal sensory nerve roots. The condition was first described by Sinreich in 2004. We conducted a systematic review of CISP cases published on PubMed to identify common clinical presentations, along with neurophysiological, radiological, cerebrospinal fluid (CSF), and other findings. Our review included a total of 22 patients from 8 articles. Many patients presented with gait difficulties and sensory ataxia and were found to have normal nerve conduction studies (NCS) and electromyography (EMG) but exhibited characteristic abnormalities in somatosensory evoked potentials (SSEP), elevated CSF protein levels, thickened nerve roots on contrast-enhanced lumbar spine MRIs, and histological changes on nerve root biopsies. Clinical improvement was observed following treatment with steroids and/or intravenous immunoglobulin (IVIG). The study concluded that while CISP is rare, it is an important clinical entity to consider, as accurate diagnosis and appropriate treatment can lead to significant improvements in neurological symptoms and disabilities.

Bibliographic Details

Provide Feedback

Have ideas for a new metric? Would you like to see something else here?Let us know